Bleakley Financial Group LLC Has $699,000 Position in The Allstate Co. (NYSE:ALL)

Bleakley Financial Group LLC increased its position in shares of The Allstate Co. (NYSE:ALL) by 19.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,990 shares of the insurance provider’s stock after acquiring an additional 827 shares during the quarter. Bleakley Financial Group LLC’s holdings in Allstate were worth $699,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of ALL. Vanguard Group Inc. raised its position in shares of Allstate by 11.5% during the third quarter. Vanguard Group Inc. now owns 32,270,589 shares of the insurance provider’s stock worth $3,595,266,000 after purchasing an additional 3,322,673 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in Allstate by 9.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 6,039,351 shares of the insurance provider’s stock valued at $669,221,000 after buying an additional 499,056 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Allstate by 3.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 5,926,917 shares of the insurance provider’s stock valued at $660,318,000 after buying an additional 172,250 shares during the period. Geode Capital Management LLC increased its position in shares of Allstate by 1.1% during the first quarter. Geode Capital Management LLC now owns 5,815,257 shares of the insurance provider’s stock worth $643,015,000 after acquiring an additional 63,438 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Allstate by 1.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 4,239,513 shares of the insurance provider’s stock valued at $472,324,000 after acquiring an additional 53,821 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Trading Up 0.7 %

ALL stock opened at $166.81 on Friday. The Allstate Co. has a one year low of $100.57 and a one year high of $174.57. The stock has a market cap of $43.88 billion, a price-to-earnings ratio of -134.52, a price-to-earnings-growth ratio of 0.42 and a beta of 0.52. The company has a fifty day moving average price of $163.04 and a two-hundred day moving average price of $145.13. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.37 and a quick ratio of 0.37.

Allstate (NYSE:ALL) last announced its earnings results on Thursday, February 8th. The insurance provider reported $5.82 EPS for the quarter, topping the consensus estimate of $3.87 by $1.95. The business had revenue of $14.83 billion during the quarter, compared to the consensus estimate of $12.69 billion. Allstate had a negative net margin of 0.33% and a positive return on equity of 2.67%. Allstate’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($1.36) EPS. Equities analysts anticipate that The Allstate Co. will post 13.41 EPS for the current year.

Allstate Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 1st. Investors of record on Monday, March 4th were issued a dividend of $0.92 per share. This is a boost from Allstate’s previous quarterly dividend of $0.89. This represents a $3.68 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend was Friday, March 1st. Allstate’s dividend payout ratio (DPR) is presently -296.77%.

Insider Activity at Allstate

In other Allstate news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the transaction, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the transaction, the insider now directly owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the sale, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

ALL has been the topic of several recent research reports. Piper Sandler lifted their price target on Allstate from $172.00 to $188.00 and gave the company an “overweight” rating in a research note on Monday, April 1st. Roth Mkm boosted their target price on Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a research note on Monday, April 8th. UBS Group raised their price target on shares of Allstate from $171.00 to $185.00 and gave the stock a “buy” rating in a research note on Monday, February 12th. Morgan Stanley upgraded shares of Allstate from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $117.00 to $171.00 in a report on Thursday, January 4th. Finally, TD Cowen began coverage on shares of Allstate in a research note on Wednesday, January 10th. They issued an “outperform” rating and a $193.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and an average target price of $172.59.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.